By Adria Calatayud Novartis's Sandoz generic-drugs unit has received approval from the U.S. Food and Drug Administration for biosimilar medicine Tyruko to...
Novartis's Sandoz generic-drugs unit has received approval from the U.S. Food and Drug Administration for biosimilar medicine Tyruko to treat relapsing forms of multiple sclerosis.
Sandoz said Friday that the drug--which was developed by Polpharma Biologics and for which the Swiss company entered into a global commercialization agreement in 2019--is approved to treat all indications covered by reference medicine Tysabri for relapsing forms of multiple sclerosis. Biosimilars are near-replicas of already approved biologic drugs.
This makes Tyruko the first FDA-approved biosimilar for relapsing forms of multiple sclerosis, Sandoz said. The approval was based on robust Phase 1 and 3 clinical studies, the company said.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
CVS pushes further into generic drugs with Sandoz partnership for new discount HumiraCVS is looking to strengthen its foothold in the biosimilars market, which is expected to grow to $100 billion over the next six years.
Consulte Mais informação »
FDA says to stop using 2 eye drop products because of serious health risksUsing eye drops contaminated with bacteria can lead to a 'life-threatening infection,' FDA warns.
Consulte Mais informação »
Vaccine approved by FDA to prevent RSV in infantsFDA grants approval on RSV vaccine.
Consulte Mais informação »
FDA cracks down on companies that sell unauthorized vapes to kids: ‘We will hold anyone accountable’The FDA has sent warning letters to 15 companies for selling “unauthorized e-cigarette products' — otherwise known as vapes — disguised with kid-enticing designs, according to a press release.
Consulte Mais informação »
In a new warning, FDA urges people to stop using contaminated eyedropsThere are no reports yet of injuries from the drops, but the agency warned against using the products because of fungal and bacterial contamination.
Consulte Mais informação »
US FDA panel votes against use of Medtronic's blood pressure treatment device By ReutersUS FDA panel votes against use of Medtronic's blood pressure treatment device
Consulte Mais informação »